Overexpression of Krüppel-Like Factor 9 Enhances the Antitumor Properties of Paclitaxel in Malignant Melanoma-Derived Cell Lines

Over the past decade, the treatment of metastatic melanoma has improved significantly due to the development of innovative therapies, such as drugs that target the BRAF/MAPK kinase pathway and the PD-1 pathway. However, these therapies do not work for all patients, highlighting the need for addition...

Descripción completa

Detalles Bibliográficos
Autores principales: Altonsy, Mohammed O., Song-Zhao, George X., Mostafa, Mahmoud M., Mydlarski, Paule Régine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144003/
https://www.ncbi.nlm.nih.gov/pubmed/37111314
http://dx.doi.org/10.3390/ph16040557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144003/
https://www.ncbi.nlm.nih.gov/pubmed/37111314
http://dx.doi.org/10.3390/ph16040557

Ejemplares similares